| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |